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Purification of Blood Coagulation Factors II, YII, D( and X
from Bovine Citrated Plasmal
P. RprrBns 2 and H. C. Hnrrlrnn
Department of Internal Medicine, Laboratories of Cardiobiochemistry and Blood
Coagulation Biochemistry, University Hospital Leiden, Leiden
Abstract. The bovine coagulation factors II, VII, IX and X were Key llords
separated from other plasma proteins, and each factor was obtained in a Purification
largely pure state by various chromatographic procedures in the pre- Prothrombin
sence of diisopropylfluorophosphate (DFP). Factor X was separated FactorVII
from factors II, VII, and IX by DEAE Sephadex chromatography, fol- Factor IX
lowed by G-100 filtration and hydroxylapatite chromatography. Separa- Factor X
tion of factors II and IX from factor VII was achieved by chromato- Bovine plasma
graphy on DEAE cellulose, followed by G-100 gel flltration and hydro-
xylapatite chromatography. Factors II and IX were separated by preparative polyacry-
lamide electrophoresis
After DEAE cellulose chromatography, factor vII was purified by gradient elution
from hydroxylapatite.
Introduction
The problem of obtaining coagulation factors II, VII, IX anil X from
plasma in a pure state has been a particularly stubborn one, and this difficulty
has retarded progress in coagulation biochemistry appreciably. Methods
1 The investigations were supported by the Netherlands Foundation for Chemical
Research (SoN) and Fundamental Medical Research (FUNGO), with financial aid from
the Netherlands Organization for Advancement of Pure Research (ZWO). The skillfull
technical assistance of Mrs.J.TnN VmN IN 'r Vnr,o, Mrs' B.H.M'Kop-KrnqssrN and
Miss F. L.qrrra,lrrn is gratefully acknowledged.
, The work presented in this publication is part of the PhD thesis of one of the authors
(P.R.).
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giving partial separation and yielding one or two of these factors in a pure
state from the same plasma sample have occasionally been published since
1964.In this article, procedures will be described by which each of the four
factors can be obtained separately from the same batch of bovine plasma,
the resulting products being free of any other coagulation factor activity
and very pure with respect to contaminating proteins. The initial steps con-
sist of aluminum hydroxide adsorption and ammonium sulfate precipita-
tion, as described in the literature for human or rabbit citrated plasma
16, 7, 12, 32, 41,441. The other methods applied include chromatography,
gel filtration and preparative polyacrylamide electrophoresis,3 partly along
the lines indicated by investigations on the purification of single coagulation
factors [5,  8,  9,  13,  14,  16,  l '7 ,25,27,29,34-36,  40,  43,45] .  Fol lowing a
suggestion of JecrsoN and He,NanlN [17], we added DFP, 10-4 u, to all pre-
parations and buffer solutions after the ammonium sulfate precipitation step
to prevent activation of the coagulation factors.
Materials and Methods
Chemicals and Special Reagents
Aluminum hydroxide moist gel batch No.0340600, kaolin light, and DFP were obtained
from British Drug House. Trizma base l2l, hemoglobin, egg albumin, cytochrome c and
tetra-methylethylene diamine (Temed) were purchased from Sigma. DEAE cellulose
(DE-32) was obtained from Whatman Biochemicals. DEAE Sephadex A-50, Sephadex
G-100 and dextran blue 2000 were obtained from Pharmacia. Hydroxylapatite Biogel,
HTp No.91 12. was obtained from Biorad. Acrylamide and N,N'-methylene-bis-acrylamide
were products of Fluka. Liver alcohol dehydrogenase and pancreas trypsin were obtained
from Boehringer Mannheim. Rabbit antitotal bovine serum-antiserum was obtained from
the Central Laboratory of the Netherlands Red Cross. Al1 other chemicals were of
analytical grade and purchased from Merck'
Thromboplastin from bovine brain was prepared according to ownnN and AAs [33].
Phospholipid was isolated from the cephalin fraction of human brain according to Mrl-
srom [30] and suspended in veronal acetate buffer, pH 7.35, to a concentration of 0.9 mg
protein per ml immediately before use. Factor-Il reagent was prepared analogously to the
method of Kolr-nn et at.1211, using bovine instead of human matefials. Factor-VII reagent
was prepared according to the method of LrcnNBn and DEurscn 1241, as modified by
S\I/Anr et at. 1441. Factor IX-deficient plasma was obtained from a patient with severe
hemophilia B (factor lx ll). Factor-X reagent was prepared either by adding a prepara-
3 Abbreviations: DFP - diisopropylfluorophosphate i prep. p.a.a. : preparative poly-
acrylamide electrophoresis; PPSB : preparation containing prothrombin, proconvertin,
Stuart-Power factor and antihemophilia factor B.
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tion of factors II and VII to BaSOn-adsorbed oxalated bovine plasma or by neutralizing
and precipitating factor X from normal bovine plasma with a specific antiserum against
bovine factor X.
Assay of Blood Coagulation Factors
The activities of factors II, VII, and X were determined in one-stage assays as described
for factor II by Korrnn et al.1211. Factor IX activity was estimated as described by Vrrr-
KAMI et al. 1461. Factor Xa was determined as described by Dn LnNcn and HErr.mnn [23].
Normal bovine plasma was obtained after centrifugation of blood (15 min, 1,000s'; and 30
min, 1,500 g) drawn into one-tenth by volume of trisodium citrate, 0.14 M. Hematocrit
values were about 40 l. It is defined that 1 ml of normal bovine plasma with a coagulation
factor activity of 10O)( contains 1 U of activity of each of the factors II, VII, IX or X.
Initial Steps of Purffication Procedure
After adsorption of factors II, VII, IX and X from bovine citrated plasma onto alu-
nrinum hydroxlde (l% final concentration) at 4 "C, the adsorbent was washed with Na-
EDTA, 0.3 ru, pH 8.0; and Na-citrate, 0.1 rvr, pH 8.0. The factors were eluted from the
adsorbent with phosphate buffer, 0.25 lr, pH 8.0 1441, and concentrated by ammonium sul-
fate precipitation between 35 and 65 f saturation. For factors II and X, a 200-fold puri-
fication was obtained at a yield of approximately 301. For factors VII and IX, the yield
and purification were considerably higher, probably due to activation of these factors. The
ammonium sulfate concentrate was dialyzed against 0.02 rr.r K-phosphate * 0.1 u NaCl *
DFP,0.1 mrrr, pH 6.8.
This preparation was called PPSB-2, and was used for separation of coagulation
factors II, VIL IX and X by anion exchange chromatography.
Chromatography
All chromatographic procedures were performed at 4 "C. The buffers contained DFP,
0.1 mu. DEAE Sephadex was equilibrated in potassium phosphate buffer, 0.02 ru, pH
6.8 * NaCl, 0.1 rra. DEAE cellulose was equilibrated with potassium phosphate buffer,
0.05 rrl, pH 6.8. Conditions for elution of coagulation factor activity are described in the
legends to the figures.
Gel filtration on Sephadex G-100 was done in Pharmacia K 25/100 columns, using
phosphate butrer, 0.2 tu, pH 6.8, at a flow rate of 3-6 ml/cm,/h. Assuming a linear relation
between the logarithm of the molecular weight and the elution volume of the protein [],
estimation of molecular weights was done on G-100 columns precalibrated with dextran
blue 2000, liver alcohol dehydrogenase, egg albumin, pancreas trypsin and cytochrome c.
Hydroxylapatite was equilibrated in potassium phosphate buffer, 0.075 rr.r, pH 6.8. On
the column, a linear gradient was established to potassium phosphate, 0.5 rra, pH 6.8.
Before application to the hydroxylapatite column, the samples were made 0.075 lr in
phosphate.
Protein contents were estimated after Lowny et al.1261, or by measuring the extinction
at 280 nm (ZeiB PMQ II spectrophotometer). Immunoelectrophoresis was performed
according to Scmrnncorn [39] on microscope slides.
Column effiuents were analyzed conductometrically with the LKB Conductolyzer.
Concentration of protein samples was done in Amicon ultrafiltration cells using UM-10
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membranes. The UV absorbancies of column effiuents were measured with the aid of an
LKB Uvicord lI monitor.
P o Iy ac ryInnid e Ele c t r o P ho r e s i s
Analytical polyacrylamide electrophoresis was performed according to D.c'us uol'
using a 7.5-percent gel of 2.8 I cross-linking. Amido black was used for protein staining'
Glycoproteins were stained with PAS reagent, according to Knvzpn [20]. Lipoproteins
were stained with sudan orange IlI, according to PRATT and DaNcnnrrrm [37r.
prep. p.a.a. was performed in a 7-percent separating gel, 2.8 % cross-linking, using the
Quictft 'Prep Page' equipment. As a buffer system, borate buffer according to Gon'por't
and I-ours [15] was used. Bromophenol blue served as a tracking dye. The elution buffer
did not contain DFP.
o 20 40 50 80 '100 120120 '130
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Fig.L DEAIi Sephadex chromatography of PPSB-2 in 0.02 rra K-phosphate*0.I u
NaCl*0.l mrra DFP, pH 6.8. 70 ml of protein solution (21 mg/ml) was applied. After
50 ml of effiuent had been collected, a gradient of 2 x 350 ml was started, ranging from
0.02 K-phosphate * 0.1 M NaCl to 0.02 rr,r K-phosphate * Lvr NaCl * 0.1 mrra DFP, pH 6.8.
Fraction volume: 2.8 ml. Bed dimensions of anion exchanger: 35 cm x 2'5 cm'
O-Protein, E280nmi I- factor-Il activity; 1- fasfs1-\'Il activity; a-factor-
IX activity; 1-fasf61-X activity; - ionic strengtlr, p'
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Fig. 2. DEAE c,ellulose chromatography of semipurified coagulation factor preparation
(fractions 125-156 from DEAE Sephadex, fig. l). 90 ml of protein solution (8.3 mg/ml) in
0.05 Ir,t K-phosphate * 0.1 mnr DFP, pH 6.8, was applied to DEAE cellulose equilibrated
in the same bufftjr. A gradient was used of 2 x 250 ml, starting at 0.05 rvr K-phosphate
*0.1 trl NaCl*0.1 mM DFP, pH 8.0, to 0.05 rra K-phosphatei0.5 rra NaCl*0.l mrra
DFP, pH 8.0. Bed dimensions of anion exchanger: 35 cn x 2.5 cm. Fraction volume :
4.0 ml. O- Protein, Ezaom; I- factor II; r- factor VII; a- factor IX'
x- factor X; - ionic strength, p.
Results
Separation of Factor X by DEAE Sephadex Chromatography
The result of a typical experiment in which PPSB obtained from 8 I of
plasma was separated on Sephadex A-50 is shown in figure 1. With the use
of a linear NaCl gradient, factors II and IX were eluted at an ionic strength,
p:0.48, and factor VII at p:0.50. Factor-X activity was eluted both at
p:0.50 and 0.57. By coagulation factor assays, the first peak of factor-X
activity was shown to coincide with factor Xu and the second peak with
factor X. This second peak (fractions 157-180) served as a source for pre-
paring pure factor X by procedures to be described later. For further puri-
fication of factors II, VII, and IX, fractions 125-156 were pooled and
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Fig.3. Hydroxylapatite chromatography of a coagulation factor preparation containing
mainly factors II and IX after G-100 gel filtration. Before chromatography, the sample
*r" oitot"o twice its volume with distilled water. Hydroxylapatite was equilibrated in
0.075 rrr, pH 6.8 phosphate buffer, + DFP, 0.1 mrr'r' Linear gradient:2 x 2O0 ml' starting
at phosphate concentration of 0.075-0.5 rra, pH 6.8 + DFP, 0.1 mIrl. Dimensions of hydro-
xylapatite &d:25 cmx2.5 cm. Fraction volume:4.o ml. Inorganic phosphate was
determined according to suMNER 1421. o-Protein; I- factor II; ^- factor vII;
o- factor 11; 1- factor X; - inorganic phosphate (Pi), tr't.
rcchromatographed on DEAE cellulose after dialysis again;t phosphate
buffer, 0.05 u, pH 6.8. As observed from immunoelectrophoretic analysis
and polyacrylamide-gel electrophoresis, this preparation still contained more
than l0 components, including albumin and p-globulins.
Separation of Factor VII by DEAE Cellulose. Chromatography
Figure 2 shows that rechromatogfaphy on DEAE cellulose of a semi-
purified coagulation factor preparation (fractions 125-156, fig.l) resulted in
elution of factors II and IX at ionic strengthl:0'38' The greater part of
factor-Vll activity was found to emerge from the column at p,:0'44, coin-
ciding with factor-X activity. The main protein peak (ffactions 40-60) serYed
as a source of factors II and IX; factor VII was further purified from frac-
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tions 61-90. This elution profile differed from that observed by prcHrr and
Sirann [35], who found factors II and vII to coincide and to be eluted well
before factors IX and X.
Purification of Bovine Factors II and IX
Fractions 40-60 of the eluate from DEAE cellulose which contained
factor-Il and factor-IX activity (fig.2) were pooled and further freed of
factor vII activity and some contaminating protein by gel filtration on
sephadex G-100. The elution volumes for both factor II and factor IX
corresponded to a molecular weight of 82,000 [l].
Further purification and partial separation offactor II and factor IX was
achieved by chromatography on hydroxylapatite (fig.3). contaminating
protein material was eluted at phosphate molarity 0.14 rvr, together with a
Ctotting time factor ll, sec
10 30 50 70 90
ffi
90 130 170 210 250
Clotting time factor lX, sec
Fig.4. Analytical polyacrylamide electrophoresis. Gel 1: fractions 40-60 after DEAE
cellulose (fig.2)"containing factors II, VII, and IX; l50pg protein. Gel 2A: fractions
108-140 after hydroxylapatite (fig.3), containing mainly factor-Il activity, contaminated
with factors vII and IX; 300pg protein. Gel 28: factor-Ir and IX assays in 0.5-cm slices
of a gel, run parallel to gel 2,{ with the same sample. Extraction of coagulation factor
activity with 0.5 ml of veronal acetate buffer, pH7.4. Horizontally: clotting times;verti-
cally: excised part of the gel. Gel 3 : fractions 95-104 after prep. p. a. a. (fig. 6), containing
only factor-Il activity. 1- Factor II; a- factor IX.
@
Purihcatim of(
small amount of factor-Il a
O.l9 n PhosPhate. Factor D( t
whereas factor II had a broar
phmphate- No activitY waselr
reported bY some authors [19
Judged from the results of
fractions 96-107 (fig'5, gel 2/
xylapatite column had two ot
elution of the coagulation fa
amide electroPhoresis, factor
II (fig.4 and 5, Parts 2B)'
The Pooled fractions 108-
tration 0.05 r'r bY dilution wi
o@
Fig'. 5. AnalYtical PolYacrYla
cellulose (fig.2) containing fad
96-107 after hYdroxYlapatite (fi
Gel 28: factor-Il and factor-IX
tbe same samPle. Extraction of
buffer, PH 7.4. HorizontallY: r
factor-IX PreParation after P:
l-- Factor It; 1- factor
ctd
t)
F
t)
Clol
]T and
d well
ained
ed of
n o n
rr IX
lwas
rting
ith a
\E
DS
d
es
,r
i-
c
Purification of Clotting Factors II, VII, IX and X 9
small amount of factor-Il activity. Activated factor VII was eluted at
0,19 r'r phosphate. Factor IX emerged in a sharp peak at 0.22 rt phosphate,
whereas factor II had a broad elution profile ranging from 0.22 to 0.30 tr,t
phosphate. No activity was eluted at higher phosphate concentration, as was
reported by some authors fl9,27, 441.
Judged from the results ofpolyacrylamide-gel electrophoresis, the pooled
fractions 96-107 (fig.5, gel 2A) and 108-140 (fig.4, gel 2A) from the hydro-
xylapatite column had two components in common. Slicing of the gels and
elution of the coagulation factor activity demonstrated that on polyacryl-
amide electrophoresis, factor IX has a somewhat greater mobility than factor
tr (fig.a and 5, parts 2B).
The pooled fractions 108-140 (fig.3) were brought to phosphate concen-
tration 0.05 u by dilution with distilled water and concentrated by Amicon
Clotting time factor ll, sec
'r0 30 50 70 90 110
Fig.5. Analylical polyacrylamide electrophoresis. Gel'1 : fractions 40-60 after DEAE
cellulose (fig.2) containing factors II, VII, and IX; 150 pg protein. Gel 24: fractions
96-lO7 after hydroxylapatite (fig. 3), containing mainly factors IX and II; 100 pg protein.
Gel 2B: factor-Il and factor-IX assays in 0.5-cm slices of a geI, run parallel to gel 2A with
the same sample. Extraction of coagulation factor activity with 0.5 ml of veronal acetate
buffer, pH 7.4. Horizontally: clotting times; vertically: excised part of the gel. Gel 3:
factor-IX preparation after prep. p.a.a., contaminated with factor II (about 10%).
I- Factor II; 3- factor IX.
@@o
70 r10 150 190
Ctotting time factor lxj sec
10 Rnrrcns/Hurarrn
UM-10 membfane filtration. This sample was submitted to preparative poly-
acrylamide electrophoresis. As is shown in figure 6, factor IX was found to
be eluted before factor IL Polyacrylamide electrophoresis gave an extensive
loss of factor-Il activity. Apart from factors IX and II, at least two other
proteins could be detected in the protein pattern. No factor vI or thrombin
was found in the eluted protein peaks. Fractions 95-104 were pooled and
injected into rabbits to obtain an antiserum against bovine factor II [38]'
Fractions 6G-94 were pooled and used for the adsorption from the antiserum
of those antibodies not directed against bovine prothrombin'
0.05
- 0.04
r,i o.oz
0 2 0 + 0 6 0
Fraction number
Fis.6.Ptrtification of factor II by preparative polyacrylamide gel electrophoresis. 10 ml
or pooted fractions 108_140 (fig. 3) were applied on a gel (acrylamide, 7 %; cross-linking'
Z.iy) of 7 cm length. As electrode buffer, borate, 0'05 rr'r, pH 9'3' was used' As elution
U.rn"r, fti., 0.05 ;, pH 7.5, was used' The gel column was cleaned by I h preelectro-
phoresis, and the nrn was made at 50 mA constant current' At the point indicated by the
arrow, bromphenol blue (used as a marker) eluted from the column. Fraction volume:
2.8 ml. O- Protein, Ezsgnm; l- factor II; o- factor IX'
On analytical polyacrylamide electrophoresis (fig'4, gel 3), factor-Il pre-
paration showed one main band, containing factor-Il activity, and a minor,
more anodal band, which apparently had no coagulation factor activity.
staining of the gels with PAS reagent demonstrated that the main band
contained glycoprotein. The gels could not be stained with Sudan orange III.
Table I shows the overall result of the purification procedure for factor II
from bovine plasma in a representative xperiment. In a set of five experi-
ments, the results were always qualitatively equal, but large variations were
observed in the overall yield of factor II after hydroxylapatite chromato-
graphy (between 2 and 14ft) and prep. p. a. a. (between 0'5 and 3 \)'
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Table I. Purification of factor II from bovine plasma.
R€sults of a representative experiment starting with 16 I of bovine plasma
1 l
Frai<n Volume,
ml
Concen- Total,
tration, U
U/ml
Protein, Spec.act.,
mg/ml U/mg
Yield, Puri-
% fication
Phsma 16,000
PPSFI 2,140
PPSF2 80
DEAE Sephadex 160
DEAE cellulose 88
c-lm 92
Hydroxylapatite 132
Prcp. p.a-a. 5M
1 16,000
4.20 8,990
60 4,800
28 3,480
35 3,080
24 2,200
12 1,584
0.7 358
75 0.013 100 I
5.2 0.81 56 60
27 2.23 30 170
8.4 3.35 22 260
l2.t 3.64 19 280
8.0 3.0 l+ 230
0.95 12.8 10 960
0.08 8.75 2.5 640
Tabtc II. Purification of factor IX from bovine citrated plasma.
Re$lts of a representative experiment starting with 16 I of bovine plasma
Frdln Volume, Concen- Total,
ml tration U
U/ml
Protein, Spec.act,, Yield, Puri-
mg/ml U/mg % fication
Phrna
PPSFI
PPSF2
DEAE S@hadex
DEAE cellulose
Cr-lm
If:drcxylapatite
Prcp. p.aa
1 16,000
10.2 21,800
1,600 l28,ooo
50 8,000
280 24,@O
240 22,rOO
60 7,920
40 7,530
0.013 100 1
2.0 136 150
59 800 4,550
6.0 50 4@
23 t55 1,780
30 138 2,310
33 50 2,540
200 47 15,400
16,000
2,140
80
160
88
92
132
188
75
5.2
27
8.35
t2. l
8.0
1 . 8
0.2
Separation of factor IX from contaminating.factor-Il activity, as found
in fractions 96-107 from the hydroxylapatite column (fig.3), was achieved by
pr€p. p.a.a. Factor IX migrated faster than factor II, as had been observed
also for prep. p. a.a. of a factor-Il preparation (fig. 6). As is shown in figure 5,
pl 3, fractions with maximal factor-IX activity showed one main protein
band on analytical polyacrylamide electrophoresis, this band coinciding with
factor-D( activity, and being stainable with PAS reagent. These fractions
12 REEKERs/HEMKER
were used to obtain antibodies against factor IX in rabbits [38]. A minor
contamination (about l0 l) with possibly factor-Il activity was observed.
Table II shows the overall result of the purification procedure for factor
IX from bovine plasma in a representative xperiment. The high yield and
purification are undoubtedly due to activation of factor IX during the puri
fication procedure.
Purffication and Isolation of Bovine Factor VII
Isolation of factor vII started from fractions 61-90 from DEAE cellulose
chromatography (fig.2). considerable.purification of factor vII was achieved
by gel filtration on G-100. The elution volume for factor vII corresponded to
a molecular weight of about 68,000. No factor-Il or factor-IX activity was
observed. The fractions having maximal factor-Vll activity were pooled,
concentrated and used for further purification by hydroxylapatite'
As is demonstrated in figure 7, factor VII was eluted at a phosphate
concentration of 0.19 rt, whereas the main portion of protein material was
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not retarded on hydroxylapatite at the starting phosphate concentration
t0.07,5 u). The elution profile of factor-Vll activity did not coincide with the
protein elution proflle, indicating that factor VII was still contaminated with
other protein material.
On analytical polyacrylamide electrophoresis (fig.8, gel 2), the main pro-
tein band had factor-Vll activity and it could be faintly stained with PAS
reagent. Another minor, more anodal protein band was observed, the nature
of which could not be determined. The factor-Vll band corresponded well
s'ith the band representing factor-Vll activity in the pooled fractions 61-90
from the DEAE cellulose column (fig.8, gels 1A and B).
So little material was left after the many stages of the purification proce-
dure that pooled fractions 3l-40 after hydroxylapatite chromatography
rfig-7) x'ere used as a factor-Vll preparation, although analytical poly-
ac4lamide electrophoresis suggested that further purification was still
prrssible. The preparation was used for immunizing rabbits to obtain an anti-
-ierum a-sainst bovine factor VII.
Clot t ing t ime Vl l ,  X,  sec
10 20 30 40 50 60 ?o 80 90
lx
1 *
^({r<
___-___.-x
@@@
fig.8. Analytical polyacrylamide-gel electrophoresis. Gel lA fractions 61-90 (fig.2)
after DEAE cellulose cbromatography containing factors VII and X; 130 prg protein.
C'el lB: factor-Vll and factor-X assays in slices of a gel, run parallel to gel 1A with the
ranr sample- Length of slices:0.5 cm. Extraction of coagulation factor activity from the
gek *ith 0.5 ml veronal acetate buffer, pH7.4. Horizontally: clotting times; vertically:
€rcised part of the gel. Gel 2: fractions 31-40 (fig.?) after hydroxylapatite chromato-
graphl': 4O,ag protein. ^ - Factor VII; x- factor X.
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Table III. Purification of factor VII from bovine citrated plasma'
Results of a representative experiment starting from 16 I of bovine plasma
Fraction Volume, Concen- Total,
ml tration, U
U/ml
Protein, Spec.act,,
mg/ml U/mg
Yield, Puri-
% fication
Plasma
PPSB-I
PPSB-2
DEAE Sephadex
DEAE cellulose
G-100
Hydroxylapatite
16,000
2,140
80
160
128
35
28
I
5.83
5 l
1 8
12.5
18.5
18.0
16,000
12,470
4,080
2,880
1,600
6s0
500
0.013
1 . 1
1.9
2.2
5.0
31.0 .
180
I
86
145
166
385
2,380
14,000
100
77
26
1 8
l0
4
3
75
5.2
27
8.4
2.5
0.6
0.1
Clottingtime Vll, X, sec
l0 20 30 40 50 60 70 80 90 100
Fig.9. Analytical polyacrylamide-gel electrophoresis. Gel 1: fractions 157-180 (fig. l)
after DEAE Sephadex chromatography, containing factors vII and X; 230pg protein.
Gel 2A: pooled fractions eluted from G-100 between 175-2lo ml (fig. l0); ll0pg protein.
Gel 2B: factor-Vll and factor-X assays in 0.5-cm slices of a gel (ordinate), run parallel to
gel 2A with the same sample. Extraction of coagulation factor activity with 0'5 ml veronal
acetate buffer, pH7.4. Horizontally: clotting times; vertically; €xcised part of the gel'
Gel 3: fractions 45-60 after hydroxylapatite chromatography (fig'11); 125 pg protein'
a- Factor VII; x- factor X.
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TaHe III shows the result of the purification procedure for factor VII
from bovine plasma in a representative experiment. The overall yield was
3 no and a purification of 14,000-fold was reached.
hrification and Isolation of Bovine Factor X
Fractions 157-180 from DEAE Sephadex chromatography (fie.1) served
as a starting material for the isolation of factor X, as previously reported by
JrcrsoN et al. |8} The material contained some factor-Vll activity as well.
Polyacrylamide electrophoresis revealed the presence of at least four protein
bands; the position of the main protein band correlated well with the position
where maximal factor-X activity was found in sliced gels (fig.9, gels I and 2b).
G-100 gel filtration of this preparation resulted in poor separation of
frtor X from the contaminating factor-Vll activity (fig.l0). Considerable
separation of factor X from other proteins emerging near the void volume
urs obtained.
From the elution volume of factor-X activity, a molecular weight of
about t4,(m was calculated. The fractions between the elution volumes
175-210 ml were pooled. On polyacrylamide-gel electrophoresis, this pre-
o 350
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IEr-fO. G-lm gelhltration in phosphate buffer,0.2 rr.r, pH 6.8+DFP,0.1 mrvr, of
fi'slns 157-l8O after DEAE Sephadex (fig. l). 5 ml of protein solution (3.8 mg/ml) was
rDlid- ftrnrensions of gel bed- 85 cm x 2.5 cm. Vo: 135 ml. Flow rate:3.6 ml/cmr/h.
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Fig. l l .Hydtoxylapati techromatographyoffract ionsl75-2|o(f ig.10)inphosphate
tufei O.OZS r'r, pH 6.8. Linear gradient: 2 x 150 ml phosphate,0'075-0'5 v' pH 6'8-l-
DFP. 0.1 mrr.r. Phosphate concentration was measured after Suur\tln [42]. Dimensions of
hydroxylapatite bed:22 cmx 1.5 cm. Fraction volume:2'8 ml' o- Protein;
1- f4sfe1 VII; 1.- factor X; - phosphate concentration, M.
paration showed two poorly separated bands and a weak third band. The
iwo bands coincided with maximal factor-Vll and factor-X activity in
sliced gels (fig.9, gels 2A and B). No factor-Il or factor-IX activity was
found in this preParation.
As is shown in figure 11, factor-X activity, present in the G-100 effiuent,
was eluted from hydroxylapatite at a phosphate concentration of 0.25 tu;
other protein material was not retarded by hydroxylapatite or was eluted at
a phosphate concentration of 0.19 tr'1.
Simultaneously with factor X, some factol-vll activity was eluted at
0.25 u phosphate. However, in a factor-Xa assay, factor X appeared to be
partly activated; consequently, shortening of clotting time in a factor-Vll
assay may be expected. The complete coincidence and constant fractional
ratio of factors vII and X argued in favor of this factor-vll activity to be
an artefact.
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Tdlc IV- Purification of factor X from bovine citrated plasma.
Icolt d a representative experiment starting from 16 I of bovine plasma
t7
Frrti(l Volume, Concen-
ml tration,
U/ml
Frotein, Spec.act.,
mS/ml U/mg
Yield, Puri-
% fication
Total,
U
l|m
t?sBl
F?SF2
DEAE Sephadex
G-t(n
Stdq'LDotite
l6000
2,lN
80
70
35
42
16,000
11,310
5,740
840
700
600
0.0r3
1.0
a 1
30
54
66
I
78
205
2,300
4,150
5,120
t )
5.2
27
0.4
0.4
0.2
I
5.3
72
12
20
l4
100
70
36
7
4
4
On polyacrylamide gels, the factor-X preparation from the hydroxyl-
Tft column revealed one main protein band having factor-X activity
&-X C 3); glycoprotein staining with PAS reagent gave apositive reaction
t -' trD pcition as the main band observed after protein staining with
r-lo bl'c* Three minof, more cathodal contaminants were present. No
ffi pification of this preparation was attempted, because mono-
TG.r" rnri*erum against bovine factor X was obtained by injecting into
ff rhre portions of sliced gels containing maximal factor-X activity
F+
T.ht IY shows tle overall result of the purification procedure for factor
Xfiuboryine plasma in a representative xperiment. Although considerable
riatn was obtained by DEAE Sephadex chromatography, this step
rr,mpanied by a considerable loss of factor X because only the second
Ft dfu duted bovine factor-X activity lvas used for further purification.
Tb ful yiJd of bovine factor X was in the order of 4 ft, and an approxi-
Dtdy S,ffiLfold purification was reached.
Discussion
Ou aim was to find schemes by which factors II, VII, IX and X can be
irorrrd from the same batch of bovine plasma as separate entities (fig.12).
Ltldht' our conditions, DEAE Sephadex chromatography resulted in sepa-
11li1n d magUlation factor activity from many other plasma proteins, in-
t 8 Rrmms/Hpuxm"
Fractions 125-156 Fractions 157-180
Fractions 40-60 Fractions 61-90
G-100
Hydroxylapatite
Factor Xl-- o-,,ooI
f- Hydroxyl.
I apatite
Factor Vll
Fig.12.Prxification scheme for factors II, VII, IX and X.
cluding albumin, T-globulin and fibrinogen. In accordance with other authors
[13, 18, 34,45], a partial separation was effected between the factors II and X,
the latter having a much higher affinity for the anion exchanger.
The presence of DFP appeared to be necessary for prevention of acti-
vation of coagulation factors due to chromatographic procedures, as has
been established by JecxsoN and H,c.llAfieN [17]. Even in the presence of
DFP, factor X eluted in a double peak as was observed previously by
Jrcrsox et al. $81and by MnsrouB et al. [31]. We can confirm the finding
of J,c.cKsoN and HnN,l'rreN [17] that both kinds of factor X have the same
mobility on polyacrylamide electrophoresis. We were able to demonstrate
that the protein peak eluted at the lower ionic strenght contained factor Xu,
the one at higher ionic strength only factor X [4]. Thus, DFP did not com-
pletely abolish this activated factor X. In some experiments, the peak with
factor Xu activity gave rise to double-peak formation on G-I50 gel filtration,
the two species having molecular weights of 115,000 and 88,000. Chromato-
graphy or electrophoresis in the presence of sodium dodecyl sulfate (SDS)
did not give any indication ofthe occurrence of aggregation offactor X with
PPSB-2
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other plasma material. By gel filtration, several authors determined a mole-
cuJar neight for factor X ofabout 85,000 [13, 18, 34] which observation was
*L... made for our factor-X preparation.
The best purification of factor X was achieved by taking the second part
cf the factor-X peak from DEAE Sephadex. The resulting factor-X prepara-
'irrn showed one main band on analytical polyacrylamide electrophoresis,
:nd one precipitation line on Ouchterlony plates against rabbit antitotal
bc,rine serum-antiserum or rabbit antibovine factor-X antiserum and on
immunoelectrophoresis [38].
The yield was poor, because a part of factor-X activity was left in the
nnt DEAE Sephadex peak, which was used for the purification of factors II,
VII. and IX. In the factor-X preparation, the relative amounts of factor X
'-.d fastor VII have repeatedly been found in a ratio of 10:1. It is known
rh..i pure factor X also shortens the recalcification time of factor VII-defi-
;iacr plasma containing 5O I factor X. We cannot conclude from clotting
assals that factor VII was absent in the factor-X preparation, but the factor-
\1I rtiriry- measured can be explained by the influence of factor X on the
fnt.rr-\Il assay.
Tbe factor-Vll preparation obtained after hydroxylapatite chromato-
gre?h)-. dcres not significantly shorten the recalcification time of factor X-defi-
;i6s1 !g1r'ine plasma. So, we concluded factor X to be absent in the factor-
iII prrparation. The molecular weight of bovine factor VII ranged from
:Cm to 62,000, as judged from G-100 gel filtration; this was in agreement
r:rh the observations of other investigators I l]. The yield of factor VII was
pr."rr- maidy because chromatographic procedures gave rise to activation
phrn,,rmena in the factor-Vll molecules, making the factor more labile.
t*}en DFP was added to the eluting phosphate buffer after aluminum hydro-
uJc aCsorption of factor VII from bovine plasma, a lower factor-Vll activity
ras found in the eluate than when DFP was omitted.
Factor II and factor IX could not be separated by DEAE cellulose
chromatography [9, 35, 45]. Partial separation of these factors was achieved
b1 hldroxylapatite chromatography 1271, as has been shown also for the
human coagulation factors 15, 431. In our experiments, factor II eluted at a
,o*er phosphate concentration than was found for human prothrombin.
On both analytical and preparative electrophoresis, factor IX showed a
hi_ekr electrophoretic mobility than factor II; this result was not obtained
b1 Cox and HlNaHeu [9].
Our results are in agreement with the observation of Prcnnr and SulrH
[35]. who showed factor IX to have a lower isoelectric point than factor II.
20 Rrmnns/llmrrrn
The molecular weights of bovine factors II and IX were determined by
G-100 gel filtration to be approximately 82,000 for both factors [9, 45].
Controversially, no indication of multiple factor-Il elution patterns or
factor-Il polymorphism was obtained in the present study P',3,22,287.
The factor-Il preparation still contained contaminating proteins. On
immunoelectrophoresis of this preparation against antitotal bovine serum-
antiserum, two precipitation lines were observed, as was also the case with
rabbit antibovine prothrombin antiserum, obtained by injecting this pro-
thrombin preparation into rabbits [38]. On polyacrylamide electrophoresis
of the factor-Il preparation, one main protein band, coinciding with factor-Il
activity, was observed, together with a thin, slightly more anodal protein
band.
Factor-IX preparations still contained about 5l factor'll activity. On
polyacrylamide electrophoresis, one protein band coinciding with factor-IX
activity was observed. Immunodiffusion experiments of the preparation
against rabbit antibovine factor-IX antiserum showed only one precipitation
line, as was also the case for immunoelectrophoresis experiments with the
same antiserum [38].
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